ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "health behaviors"

  • Abstract Number: 0098 • ACR Convergence 2021

    Patients with Chronic Inflammatory Rheumatic Diseases Report a Lower Frequency of Infections Than Controls and They Protect Themselves Well Against SARS-CoV-2 Transmission

    Iulia Roman, Ioana Andreica, Xenofon Baraliakos, Uta Kiltz and Juergen Braun, Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany

    Background/Purpose: The SARS-CoV-2 pandemic has affected life in most countries around the world for more than a year now. It is not entirely clear if…
  • Abstract Number: 1608 • ACR Convergence 2021

    Sources of Information About SARS-CoV-2 Used by Patients with Chronic Inflammatory Rheumatic Diseases (CIRD)

    Ioana Andreica, Iulia Roman, Xenofon Baraliakos, Uta Kiltz and Juergen Braun, Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany

    Background/Purpose: Patients with chronic inflammatory rheumatic diseases (CIRD) may be at increased risk of Corona Virus Disease 2019 (COVID-19).1 The quality of information obtained plays…
  • Abstract Number: 0122 • ACR Convergence 2021

    Clinical Impact of a Digital Behavioral Therapy for Fibromyalgia Management: A Randomized Controlled Trial

    Stephanie Catella1, Michael Gendreau2, Nicolette Vega1, Allison Kraus1, Michael Rosenbluth1, Sherry Soefje3, Shishuka Malhotra4 and Lesley Arnold5, 1Swing Therapeutics, San Francisco, CA, 2Gendreau Consulting, LLC, Poway, CA, 3Excell Research, Oceanside, CA, 4Neuro-Behavioral Clinical Research, North Canton, OH, 5University of Cincinnati, Cincinnati, OH

    Background/Purpose: Recommendations for fibromyalgia management include both pharmacologic and nonpharmacologic treatments. Cognitive behavioral therapy (CBT) has demonstrated level 1A evidence for fibromyalgia management, though access…
  • Abstract Number: 1609 • ACR Convergence 2021

    SARS-CoV-2 Vaccination Willingness and Its Predictors in Patients with Chronic Inflammatory Rheumatic Diseases (CIRD)

    Iulia Roman, Ioana Andreica, Xenofon Baraliakos, Uta Kiltz and Juergen Braun, Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany

    Background/Purpose: Whether patients with chronic rheumatic diseases (CIRD) are at increased risk of developing severe COVID 19 infections is not entirely clear. However, some DMARDs…
  • Abstract Number: 0131 • ACR Convergence 2021

    Association of Numeracy with Medication Non-Adherence in Systemic Lupus Erythematosus

    Mithu Maheswaranathan1, Amanda Eudy2, Ann Barr2, Catherine Howe3, Stacy Bailey4, Susan Hastings1, Jennifer Rogers2, Jayanth Doss2, Lisa Criscione-Schreiber1, Rebecca Sadun2, Megan Clowse5 and Kai Sun1, 1Duke University School of Medicine, Durham, NC, 2Duke University, Durham, NC, 3Duke University Hospital, Durham, NC, 4Northwestern University, Evanston, IL, 5Duke University, Chapel Hill, NC

    Background/Purpose: Over 33% of U.S. adults have limited health literacy or numeracy. Limited health literacy and numeracy have been associated with higher disease activity and…
  • Abstract Number: 1612 • ACR Convergence 2021

    Factors Associated with COVID-19 Vaccine Hesitancy Among Individuals with Rheumatic Disease

    Kristin Wipfler1, Adam Cornish1, Alison Freifeld2, Patricia Katz3 and Kaleb Michaud2, 1FORWARD, The National Databank for Rheumatic Diseases, Omaha, NE, 2University of Nebraska Medical Center, Omaha, NE, 3University of California San Francisco, San Francisco, CA

    Background/Purpose: COVID-19 vaccination efforts are ongoing and there is a need to understand factors associated with vaccine hesitancy. Individuals with rheumatic diseases have been uniquely…
  • Abstract Number: 0233 • ACR Convergence 2021

    Feasibility and Acceptability of an Online Intervention for Lupus Self-Management Based on the Transtheoretical Model of Change

    Katherine Carpenter1, Melissa French1, Sara Balestrieri2, Sara Johnson2, Sarah Gilman3, Cristina Drenkard4, S Sam Lim5, Maria Dall'Era6, Emily Somers7, Suzanna Zick8, Victoria Werth9, Daniel Wallace10, Melicent Miller1 and Mary Crimmings1, 1Lupus Foundation of America, Washington, DC, 2Pro-Change Behavior Systems, South Kingstown, RI, 3Wayfinder Health Strategies, Falls Church, VA, 4Emory University, Atlanta, GA, 5Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, GA, 6University of California San Francisco, Corte Madera, CA, 7University of Michigan, Ann Arbor, MI, 8Department of Family Medicine and Nutritional Sciences, Ann Arbor, MI, 9Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania and Philadelphia VAMC, Philadelphia, PA, 10Cedars-Sinai, Los Angeles, CA

    Background/Purpose: The Lupus Foundation of America (LFA) has completed a 5-year cooperative agreement with the CDC to develop and evaluate an online lupus self-management (SM)…
  • Abstract Number: 1613 • ACR Convergence 2021

    Pandemic and Patients: Examining Health-Related Behaviors of Patients with Systemic Sclerosis During the COVID-19 Pandemic

    Nancy Dorr1, Patricia Fennell2 and Lee Shapiro3, 1The College of Saint Rose, Albany, NY, 2Albany Health Management Associates, Inc. Steffens Scleroderma Foundation, Albany, NY, 3Albany Medical College, Stillwater, NY

    Background/Purpose: Prior to COVID-19, few studies examined how patients with a chronic illness, such as systemic sclerosis (SSc), react to a pandemic. This study examined…
  • Abstract Number: 0599 • ACR Convergence 2021

    Effectiveness of a Provider Led Intervention on Medication Adherence in an Urban Lupus Clinic

    Nancyanne Schmidt1, Yevgeniya Gartshteyn2, Teja Kapoor3, Laura Geraldino4, Leila Khalili5 and Anca Askanase6, 1New York Presbyterian/Columbia University Medical center, New York, NY, 2Columbia University Medical Center, Glen Rock, NJ, 3Columbia University Irving Medical Center, Leonia, NJ, 4New York Presbyterian Hospital - Columbia Campus, New York, NY, 5Columbia University Medical Center, New Haven, NY, 6Columbia University Medical Center, New York, NY

    Background/Purpose: Medication adherence is a difficult charge in SLE. Up to 75% of lupus patients are non-adherent with hydroxychloroquine (HCQ). Pharmacy refill data measured by…
  • Abstract Number: 1621 • ACR Convergence 2021

    Self-reported Transition Readiness of Adolescent Patients with Rheumatologic Disease: Do the Parents Agree?

    Christina Ma1, Molly Dushnicky1, Habeba Talaat1, Steffy Thomas1, Karen Beattie1, Tania Cellucci2, Stephanie Garner1, Liane Heale1, Mark Matsos1 and Michelle Batthish1, 1McMaster University, Hamilton, ON, Canada, 2McMaster Children's Hospital, Hamilton, ON, Canada

    Background/Purpose: The transition from pediatric to adult rheumatology care is associated with increased disease activity and morbidity. The parent-child relationship is a significant relationship in…
  • Abstract Number: 0601 • ACR Convergence 2021

    Racial Differences in Medication Beliefs Among SLE Patients

    D Ryan Anderson1, Amanda Eudy2, Megan Clowse3, Rebecca Sadun2, Jennifer Rogers2, Lisa Criscione-Schreiber4, Jayanth Doss2, Corrine Volis5, Theresa Coles2 and Kai Sun2, 1Duke University Hospital, Durham, NC, 2Duke University, Durham, NC, 3Duke University, Chapel Hill, NC, 4Duke University School of Medicine, Durham, NC, 5University of Wisconsin School of Medicine and Public Health, Madison, WI

    Background/Purpose: Medication adherence is essential to establishing and maintaining disease remission among SLE patients. Patients’ beliefs about treatment influence engagement and adherence to therapy. We…
  • Abstract Number: 1716 • ACR Convergence 2021

    Teratogenic Medication Use Associated with Favorable Odds of Contraception Counseling in a Cohort of Women with Systemic Lupus Erythematosus at a Large Tertiary Academic Medical Center

    Shruti Chandramouli1, Carolina Alvarez2, R. Gina Silverstein3 and Saira Sheikh4, 1Department of Internal Medicine, Division of Rheumatology, Allergy & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 2University of North Carolina at Chapel Hill, Chapel Hill, NC, 3Department of Obstetrics & Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 4University of North Carolina Thurston Arthritis Research Center, and Department of Medicine, Division of Rheumatology, Allergy and Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC

    Background/Purpose: Systemic lupus erythematosus (SLE) primarily affects women of childbearing age, who have an increased risk of pregnancy complications such as preterm labor and preeclampsia,…
  • Abstract Number: 0623 • ACR Convergence 2021

    Intervention to Improve SLE Medication Adherence

    Kai Sun1, Amanda Eudy2, Jennifer Rogers1, Rebecca Sadun2, Lisa Criscione-Schreiber1, Jayanth Doss2, Mithu Maheswaranathan1, Ann Barr2, Lena Eder3, Amy Corneli1, Hayden Bosworth2 and Megan Clowse4, 1Duke University School of Medicine, Durham, NC, 2Duke University, Durham, NC, 3Duke University Medical Center, Durham, NC, 4Duke University, Chapel Hill, NC

    Background/Purpose: Medication nonadherence is as high as 80% among SLE patients and leads to higher morbidity, mortality, and healthcare costs. Both the under-recognition of nonadherence…
  • Abstract Number: 1913 • ACR Convergence 2021

    Patient Perceptions of Telemedicine Use in Rheumatology Clinics During the COVID-19 Pandemic: An Analysis from the COVID-19 Global Rheumatology Alliance

    Mithu Maheswaranathan1, Bruce Miller2, Carly Harrison3, Rashmi Sinha4, Bugra Egeli5, Berk Degirmenci6, Emily Sirotich7, Rebecca Grainger8, Jonathan Hausmann9, Jean Liew10 and Yu Pei Eugenia Chock11, 1Duke University School of Medicine, Durham, NC, 2University of California San Diego School of Medicine, La Jolla, CA, 3LupusChat, Capitol Heights, MD, 4Systemic JIA Foundation, Cincinnati, OH, 5Boston Children's Hospital, Boston, MA, 6St. Elizabeth's Medical Center, Boston, MA, 7McMaster University, Hamilton, ON, Canada, 8University of Otago, Wellington, New Zealand, 9Beth Israel Deaconess Medical Center, Boston, MA, 10Boston University, Boston, MA, 11Yale School of Medicine, Greenwich, CT

    Background/Purpose: During the COVID-19 pandemic, healthcare systems rapidly expanded telemedicine to ensure continued access to care. Few studies have explored patient perceptions of the telemedicine…
  • Abstract Number: 0624 • ACR Convergence 2021

    Validation of a Self-reported Measure of Extent and Reasons for Nonadherence in SLE

    Kai Sun1, Amanda Eudy2, D. Ryan Anderson3, Rebecca Sadun2, Lisa Criscione-Schreiber1, Jayanth Doss2, Jennifer Rogers1, Theresa Coles2, Corrine Volis4 and Megan Clowse5, 1Duke University School of Medicine, Durham, NC, 2Duke University, Durham, NC, 3Duke University Medical Center, Durham, NC, 4University of Wisconsin School of Medicine and Public Health, Madison, WI, 5Duke University, Chapel Hill, NC

    Background/Purpose: Medication nonadherence is common in SLE and leads to increased hospitalizations, morbidity, and mortality. To better recognize nonadherence and address adherence barriers, there is…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology